Niemann-Pick type C1 (NPC1) disease is a fatal hereditary disorder characterized by a defect in cholesterol trafficking and progressive neurodegeneration in childhood. Although the NPC1 gene has been identified, the molecular mechanism responsible for neuronal dysfunction in brains of patients with NPC1 disease remains unknown. This study demonstrates that the amount of cholesterol within mitochondria membranes is significantly elevated in NPC1 mouse brains and neural cells. In addition, the mitochondrial membrane potential, the activity of ATP synthase, and henceforth the level of ATP are markedly decreased in NPC1 mouse brains and neurons. Importantly, reducing the level of cholesterol within mitochondrial membranes using methyl--cyclodextrin can restore the activity of ATP synthase. Finally, NPC1 neurons show an impaired neurite outgrowth, which can be rescued by exogenous ATP. These results suggest that mitochondrial dysfunctions and subsequent ATP deficiency, which are induced by altered cholesterol metabolism in mitochondria, may be responsible for neuronal impairment in NPC1 disease.
transport of cholesterol to the trans-Golgi network, plasma membrane, and endoplasmic reticulum (9) (10) (11) (12) . The neuropathology associated with NPC1 dysfunction is characterized by distended neurons, with an accumulation of lipid storage bodies, presence of dendritic and axonal abnormalities, and eventually neuronal loss (13) (14) (15) . However, it remains undefined whether it is the accumulation of cholesterol and/or gangliosides responsible for the disease phenotype. In this context, it has proven beneficial to utilize the BALB/c NPC1 mouse with homozygous NPC1 mutations that displays a biochemical phenotype similar to patients with NPC1 disease, including neurodegeneration (16) , irregular dendritic trees and spines (17) , and progressive tauopathy (5, 18) . There have been a number of different hypotheses formulated to explain the molecular basis of neurodegeneration in NPC1 disease. The continuous defective use of cholesterol in NPC1 neural tissues has been suggested to cause tauopathy (5, 18, 19) . With respect to neuronal gangliosides, although some studies support the case for an accumulation of gangliosides causing neurodegeneration (20) , another study indicates that an accumulation of gangliosides is not the cause for neurodegeneration in NPC1 mice (21) . A more recent study has demonstrated that impaired neurosteroidogenesis, due to disordered cholesterol trafficking, affects neuronal growth and differentiation, and that allopregnanolone treatment delays the onset of neurological symptoms and lengthens the NPC1 mice (22) .
However, the mechanism causing disrupted neurosteroidogenesis in NPC mice remains unclear.
In this report, the BALB/c NPC1 mouse model was used to investigate the molecular basis for neuronal impairment in NPC1 disease. The results reveal a novel mechanism whereby an increased level of cholesterol in mitochondria membranes adversely affects the mitochondrial membrane potential, synthesis of adenosine triphosphate (ATP), and the level of cellular ATP in NPC1 mouse brains and neurons. Importantly, neuronal impairment in neurite outgrowth was restored by the addition of ATP, providing a potentially useful therapy for NPC1 disease.
EXPERIMENTAL PROCEDURES

BALB/c NPC1
NIH Mice-The animal care and experiments using animals were carried out in accordance with the institutional guidelines. A breeding pair of BALB/c NPC1 NIH mice, heterozygous for NPC1 (NPC1+/-), were obtained from Jackson Laboratory (Bar Harbor, MA). These heterozygous mice were maintained on a low-cholesterol diet (wt/wt) and low fat 6% (wt/wt) normal mouse diet. These mice were bred to produce normal (NPC1+/+), heterozygous (NPC1+/-), and homozygous affected (NPC1-/-) mice. For all experiments using brain samples from cerebral cortices in this report, only male mice at 9 weeks of age were investigated. For preparation of primary cultures, the cerebral cortices from embryonic day 16 or postnatal day 2 mouse brains were used.
Genotype Analysis-For genotype analysis of mice and cultured cells prepared from embryos or postnatal day 2 mice, DNA was isolated from tail-tips of each mouse and polymerase chain reaction (PCR) was performed at the NPC1 locus using primer pairs as previously described (7) .
(San Diego, CL). Mouse monoclonal antibodies against cathepsin L (a lysosome marker) and cytochrome oxidase subunit I (a mitochondrial inner membrane marker) were purchased from Transduction lab. (Lexington, KY) and Molecular Probes, Inc. (Eugene, OR), respectively.
Rabbit polyclonal antibodies against voltage-dependent anion channel (VDAC: a mitochondrial outer membrane marker), fumarase (a mitochondrial matrix maker), and UCP2 (the uncoupling protein) were purchased from Affinity Bioreagents (Golden, CO), Tilburg (the Netherland), and Santa Cruz Biotech., Inc. (Santa Cruz, CA), respectively.
Electron Microscopy-Electron microscopy was performed as previously described (5) . In brief, the cerebella removed from NPC1+/+ and NPC1-/-mice at 9 week-old were rinsed with PBS and fixed and then embedded in epoxy resin. Ultrathin sections were double-stained with 2.0% uranyl acetate for 10 min and with a lead-staining solution for 5 min, and then examined using a JEOL JEM-1200EX transmission electron microscope.
Cell culture-The embryonic brains were removed on embryonic day 16 for neuronal cultures. The genotype of each embryo was determined using the tail as described above. Neuron-rich cultures were prepared from the cerebral cortex as previously described (23) . Dissociated cells were suspended in medium consisting of Dulbecco's modified Eagle's medium nutrient mixture (DMEM/F12; 50%: 50%), N2 supplements and 0.1% bovine serum albumin (BSA) and plated onto poly-D-lysine-coated six-well plates at a cell density of 2 x 10 4 /cm 2 . On day 3 of culture, more than 99% of the cultured cells were identified as neurons by immunocytochemical analysis using a monoclonal antibody against microtubule associated protein 2 (Sigma), a neuron-specific marker. To prepare astrocyte-rich cultures, the brains from postnatal day 2 mice were removed under anesthesia. After genotype analysis, the cortex was dissociated and cortical cells w were seeded in 75-cm 2 dishes at a cell density of 1 x 10 7 in DMEM containing 10% FBS as previously described (24) . After 10 days of incubation in vitro, astrocytes in the monolayer were trypsinized (0.1%) and reseeded into six-well plates. The astrocyte-rich cultures were maintained in DMEM containing 10% FBS until use.
Mitotracker Labeling-Primary neurons and astrocytes cultured for 5 and 14 days, respectively, were rinsed three times with PBS and then incubated in Hank's Balanced Salt Solution (HBSS) containing 3 µM Mitotracker JC-1 (Molecular Probes, Inc., Eugene, OR) for 20 min at 37°C. Stock solutions of 600 µM Mitotracker JC-1 were prepared in dimethyl sulfoxide (DMSO). Mitotracker JC-1 was rinsed from cells using HBSS and then cells were allowed to equilibrate in HBSS at room temperature for an additional 20 min. Fluorescent images were obtained using a Model LSM 510 laser scanning confocal microscope (Carl Zeiss Co., Ltd, Jena, Germany) equipped with a 63 x Plan Apochromat numerical aperture and 1.4 oil immersion objective. Simultaneous two-channel recording was performed using excitation wavelength of 488 and 543 nm lines of an argon laser, and fluorescence was detected using 530 and 590 nm emission filters. Fro merged images, images were adjusted to similar intensities and then merged using Adobe Photoshop 6.0.
Determination of ATP Levels in Tissues and
Cultured Cells-The brain, liver, and muscle were removed and homogenates were prepared with PBS containing protease inhibitors, Complete TM (Roche, Manheim, Germany), using a glass/Teflon homogenizer (Iuchi, Osaka, Japan) with ten up-and-down strokes at 1,000, 2,000 and 3,000 rpm, 4 respectively. The homogenates were centrifuged at 10,000 rpm for 2 min at 4°C, and then rinsed 3 times with PBS. For preparation of homogenates of cultured cells, harvested cultured cells in PBS containing protease inhibitors, Complete TM were homogenized using a glass/Teflon homogenizer, followed by centrifugation at 10,000 rpm for 2 min at 4°C, and then rinsed 3 times with PBS. The level of ATP in these samples was determined using the ATP Bioluminescence Assay Kit CLS II (Roche, Mannheim, Germany). In brief, this was performed by resuspending the pellet into 50 µl of ice-cold ATP-lysis buffer (100 mM Tris and 4 mM EDTA, pH 7.75), to which 150 µl of boiling ATP-lysis buffer was added, and the samples were incubated for 2 min at 99°C. The samples were centrifuged at 10,000 rpm for 1 min at 4°C, and resulting supernatants collected. Finally, the level of ATP was determined by combining 50 µl of the supernatant wiht 50 µl of luciferase reagent. After a 20 sec delay, chemiluminescence was measured with 2.6 sec integration time using a microplate luminometer (EG&G Berthold, Bad Wildbad, Germany). Luciferase activity was expressed as fluorescence units per µg protein.
Isolation of Brain MitochondriaCerebral cortices were isolated and homogenized in the isolation buffer (5 mM HEPES, pH7.4, 250 mM mannitol, 1 mM EGTA, 70 mM sucrose, and 0.1% fat-free BSA) using a glass/Teflon homogenizer (Iuchi, Osaka, Japan) with ten up-and-down strokes. The homogenates were centrifuged at 600 x g for 10 min at 4 C, with the resulting pellet being suspended into isolation buffer (P1), and the resulting supernatant (S1) being centrifuged at 10,300 x g for 15 min at 4°C in a Beckman SW 41 rotor. The resulting supernatant (S2), was stored and the pellet (P2) was suspended in 2 ml of isolation buffer, loaded onto 8 ml of 30% (v/v) Percoll in gradient buffer (25 mM HEPES, pH 7.4, 225 mM mannitol, 1 mM EGTA, and 0.1% fat-free BSA, and centrifuged at 95,000 x g for 30 min at 4 C. The resulting supernatant (S3), was stored and the mitochondrial pellet (P3) was rinsed with isolation buffer by centrifuging 15 min at 7,000 x g at 4 C, and then resuspended in isolation buffer. Protein concentration was determined by the bicinchoninic protein determination method (Pierce Chemical Co., Rockford, Illinois).
Subfractionation of Brain Mitochondria by
Digitonin-A 2.0% digitonin stock solution was prepared immediately prior to use by dissolving digitonin in the isolation solution (210 mM mannitol, 1 mM EGTA, 70 mM sucrose) as previously described (25) . One ml of ice-cold digitonin solution was added to 1 ml of mitochondrial protein (100 mg/ml). The resulting suspension was homogenized, and then centrifuged at 12,000 x g for 5 min at 4°C. The supernatant was removed, and the pellet was resuspended in the same volume of isolation solution. This suspension was centrifuged again at 12,000 x g for 10 min. The pellet from the second centrifugation is hereafter referred to as the "inner membrane"(IM). The supernatants from the first and second centrifugation were pooled, and fractionated by centrifugation at 144,000 x g for 1 hr at 4°C. The pellet from this centrifugation is hereafter referred to as the "outer membrane" (OM) and the supernatant the "contact sites" (CS) (26) .
Enzymatic Analysis of Complex I+III, II+III, IV
and V-The mitochondria isolated from homogenates of cerebral cortices were used for enzymatic analysis. (a) The enzyme activity of NADH-cytochrome c oxidoreductase (complex I+III) was determined as previously described (27) . In brief, a 150 µl reaction buffer (50 mM K 2 HPO 4 pH 7.4, 0.1 mM NADH, 0.1 mM cytochrome c, and 0.3 mM KCN) with and without 1.5 µM rotenone, was incubated for 5 min at 30 C, followed by the addition of 10 µl of mitochondria protein (3 µg/µl). NADH-cytochrome c oxidoreductase activity was immediately monitored at 550 nm and the difference in the reduction of cytochrome c with and without rotenone was calculated.
(b) The enzyme activity of succinate-cytochrome c oxidoreductase (complex II+III) was determined as previously described (28) . In brief, a 150 µl reaction buffer (40 mM K 2 HPO 4 pH 7.4, 20 mM sodium succinate, 50 µM cytochrome c, 0.5 mM EDTA and 0.25 mM KCN) was incubated for 5 min at 30°C, followed by the addition of 10 µl mitochondrial protein (3 µg/µl). Succinatecytochrome c oxidoreductase activity was monitored at 550 nm and the difference in the reduction of cytochrome c was calculated. (c) The enzyme activity of cytochrome c oxidase (complex IV) was determined as previously described (29) . Complex IV activity was measured as the oxidation of ferrocytochrome c by cytochrome c oxidase at 550 nm. Ferrocytochrome c was first prepared from 10% cytochrome c by reduction with sodium ascorbate and dialysis against 0.01 M K 2 HPO 4 (pH 7.0) using a 3.5 kDa exclusion dialysis membrane. A 150 µl reaction buffer (10 mM K 2 HPO 4 pH 7.4, 70 µl ferrocytochrome c) was incubated 5 min at 30°C, followed by the addition of 10 µl mitochondrial protein (3 µg/µl). Cytochrome c oxidase activity was immediately monitored at 550 nm. (d)The enzyme activity of mitochondrial complex V was determined as previously described (29) . ATPase activity was measured as the hydrolysis rate of ATP determined by a bioluminescence method. Inbrief, a 250 µl reaction buffer (10 mM K 2 HPO 4 pH 7.4, 300 mM D-mannitol, 10 mM KCl, 5 mM MgCl2, 1 mg/ml BSA, 2 µM rotenone, 0.3 mM KCN) was combined with 100 µg of mitochondrial protein. The reaction was initiated by adding 1.5 µl of 500 mM ATP (at a final concentration of 3 mM) and run for 15 min at 37°C then stopped by adding oligomycin at a final concentration of 10µM. A control experiment was performed under the same conditions in the presence of 10 µM olygomycin to obtain the nonenzymatic hydrolysis of ATP. The solution was diluted to 1/10 and ATP level was measured by luciferin-luciferase method using the ATP Bioluminescence Assay Kit CLS II (Roche, Mannheim, Germany) in a luminescence spectrometer.
For the determination of ATP synthase activity, 100 µg of mitochondrial protein from each sample was used to measure the synthesis of ATP. The reaction was initiated by adding 100 µg of mitochondrial protein into 100 µl reaction buffer (10 mM K 2 HPO 4 pH7.4, 300 mM D-mannitol, 10 mM KCl, and 5 mM MgCl2) at 37°C. After a period of 1 min, 10 µl of ADP (50 µM) was added, and the intensity of bioluminescene was recorded at 37°C, where the peak height was proportional to the amount of ATP that was synthesized.
Effect of removal of cholesterol from the mitochondria membrane -To remove cholesterol from the mitochondria membrane, a stock solution of methyl--cyclodextrin (Sigma) (150 mM) was prepared using distilled water, and then diluted into the P2 fraction derived from brains to a final concentration of 7.5 mM.
The mixture was incubated for 20 min at 37°C, followed by an additional incubation for 10 min at RT and subjected to ultracentrifugation to purify mitochondria. For the cholesterol-enrichment of mitochondria with or without methyl--cyclodextrin, a stock solution of cholesterol was prepared (5 mM in 100% ethanol) and added into the P2 fraction that was resuspended in isolation buffer (200 µl) at a final concentration of 50 µM, followed then by incubation for 20 min at 37°C. The mitochondria were rinsed twice and subjected to ultracentrifugation to purify mitochondria. The cholesterol level, protein content, and the ATP synthase activity associated with mitochondria were then determined as described above.
Immunoblot analysis-Immunoblot analysis was performed as previously described (5) . The primary antibodies used were mouse monoclonal antibodies (cytochrome c, 1: 1,000 dilution; Na+, K+, ATPase 2, 1:1000 dilution; GM130, 1:500 dilution; Bip/GRP78, 1:500 dilution; cathepsin L, 1:1000 dilution; nucleoporin p62, 1:1000 dilution; and cytochrome c oxidase subunit I, 1:1000 dilution), and rabbit polyclonal antibodies (VDAC, 1:1000 dilution; fumarase, 1:500 dilution; and UCP-2, 1:1,000 dilution). After rinsing and incubation in the presence of appropriate peroxidase-conjugated secondary antibody, the respective bands were detected with an ECL kit (Amersham Pharmacia Biotech, UK).
Morphological analysis-Cultured neurons maintained for 1, 2, and 3 days in serum-free medium in the presence, or absence of 0.5 mM ATP, 0.5 mM ADP, or 0.5 mM ATP-PNP (Roche, Mannheim, Germany) were rinsed and then fixed for 20 min at room temperature in 0.1 M PBS containing 4% paraformaldehyde fluoride. The cells were then rinsed with PBS, blocked in PBS containing 2.0% BSA, then incubated with monoclonal anti--tubulin antibody (Covance, Richmond, CA, 1:500 dilution) in PBS containing 2% BSA overnight at 4°C. The cells were then incubated with anti-mouse IgG (1 : 200) in 0.1 M PBS, 0.5% BSA for 1 h, rinsed and visualized with ABC method. Photographic images were captured using a CCD camera (DC500) (Leica Microsystems GMBH, Wetzar, Germany) attached with phase-contrast microscopy (Olympus IX70, Olympus Co Ltd., Tokyo, Japan). The ratio of neurite number/cell and neurite total length/cell was determined using an image analyzer (LSM 510, Carl Zeiss Co., Ltd, Jena, Germany). Lipid Analysis-The concentration of cholesterol was determined using a cholesterol determination kit, LTCII (Kyowa Medex, Tokyo), while the concentration of phospholipids was determined using a phospholipid determination kit, PLB (Wako, Osaka, Japan) as previously described (24) Statistical Analysis-Statistical analysis was performed using StatView computer software, and multiple pairwise comparisons among groups of data were performed using the analysis of variance (ANOVA), and the Bonferroni t-test.
Determination of cholesterol and Phosphatidylcholine (PC) transport-
RESULTS
The morphology and membrane potential of mitochondria in neurons and astrocytes isolated from mouse brains -The morphology and function of mitochondria were examined in NPC1+/+, NPC1+/-, and NPC1-/-mouse brains, and cultured cells prepared from cerebral cortices using electron and confocal microscopy. The examination of NPC1+/+ and NPC1-/-mouse brains using electron microscopy revealed that NPC1-/-mouse brains contained smaller and more rounded mitochondria, with a translucent matrix and irregular cisternae (Figs. 1a, b) . Next, the membrane potential of mitochondrial membrane within cultured neurons and astrocytes was determined using Mitotracker JC-1 (30) . When mitochondrial membrane potential is normally polarized, JC-1 concentrates in the mitochondria and aggregates, resulting in a high red/green fluorescence intensity ratio. However, with decreasing mitochondrial membrane potential, there is less aggregation of Mitotracker JC-1, therefore resulting in decreased red/green fluorescence intensity ratio. The results indicated a marked decrease in red fluorescence intensity in NPC1-/-neurons (Fig. 1e ) compared with NPC1+/+ (Fig.1c) and NPC1+/-neurons (Fig. 1d) . In contrast, there was a marked increase in green fluorescence intensity observed in NPC1-/-neurons (Fig. 1h) , compared with NPC1+/+ neurons ( Fig.1f) and NPC1+/-neurons (Fig.1g) . Similarly, there was a marked decrease in red fluorescence intensity in NPC1-/-astrocytes (Fig. 1n ) compared with NPC1+/+ neurons (Fig. 1l) and NPC1+/-astrocytes (Fig. 1m) and a marked increase in green fluorescence intensity in NPC1-/-astrocytes ( Fig. 1q ) compared with NPC1+/+ astrocytes (Fig. 1o ) and NPC1+/-astrocytes (Fig. 1p) . However, this being the case, there was no significant difference noticed in the survival of NPC1+/+, NPC1+/-, and NPC1-/-neurons and astrocytes (data not shown). Together, these results indicate that NPC1-/-neurons and astrocytes have an altered structure and altered membrane potential of mitochondria.
The Level of ATP in brain, Muscle, Liver, and Cultured Cortical Neurons -The level of ATP was determined in brain, muscle, and liver from NPC1+/+, NPC1+/-, and NPC1-/-mice at 9 weeks of age. The results indicate that the level of ATP in these tissues derived from NPC1-/-mice are significantly decreased compared to that derived from NPC1+/+ and NPC1+/-mice (Figs. 2a). As an internal control for the amount of mitochondria used in each sample, immunoblot analysis was performed to determine the amount of voltage-dependent anion-selective channel (VDAC), a protein that resides in the outer membrane of mitochondria (Figs. 2, inserts) . The addition of ATP into the liver samples (20 nmol ATP/mg protein) resulted in increased levels of ATP by approximately 15 nmol/mg protein in the three genotypes, excluding a possibility that ATP degradation rate is accelerated in NPC1-/-tissues. The level of ATP was also determined in cultured cortical neurons prepared from NPC1+/+, NPC1+/-, and NPC1-/-mice at embryonic day 16, and maintained and harvested at day 3 and day 6 of culture (Figs. 2b) . The results again indicate that the level of ATP in neurons prepared from NPC1-/-mouse brains are significantly decreased compared to neurons prepared from NPC1+/+ and NPC1+/-mouse brains.
Enzymatic analysis of mitochondria complexes I+III, II+III, IV and V using purified mitochondria from mouse brains-To determine which step(s) in ATP metabolism might be affected in NPC1-/-cells, the activities of respiratory complex I+III (NADH-cytochrome c oxidoreductase), complex II+III (succinate-cytochrome c oxidoreductase), complex IV (cytochrome c oxidase), and ATP synthase (complex V) were determined in purified mitochondrial fractions isolated from NPC1+/+, NPC1+/-, and NPC1-/-mouse brains at 9 weeks of age. The purity of mitochondria in the P3 fraction isolated from a NPC1+/+ mouse brain was confirmed by enrichment of cytochrome c oxidase, and the absence of specific markers, such as lysosomal (cathepsine D), endoplasmic reticulum (Bip/GRP78), Golgi apparatus (GM130), and plasma membrane (Na+/K+ ATpase) markers (Fig. 3a) . Furthermore, the purity of mitochondria in the P3 fraction isolated from a NPC1+/+ mouse brain was confirmed by electron microscopy (Fig. 3b) . The results indicated there was no significant differences in the enzyme activities associated with complexes I+III, II+III, and IV of the different mouse brains that were analyzed (Fig. 3c) . In contrast, the enzyme activities associated with complex V for the hydrolysis of ATP (F 1 F 0 -ATPase), and for the synthesis of ATP (ATP synthase), were significantly decreased in mitochondria isolated from NPC1-/-brains, compared with those from NPC1+/+ and NPC1+/- (Fig. 3d) . These results are consistent with and explain the observation that total ATP levels are decreased in NPC1-/-tissues (Fig. 2a) and neurons (Fig. 2b) . Since the synthesis of ATP is not entirely regulated by the coupling of sequential oxidation steps through the respiratory chain, but also by the mitochondrial uncoupling proteins (UCPs) (31), we also examined the amount of UCP-2 residing in the mitochondria fraction isolated from mouse brain using immunoblot analysis. The amount of UCP-2 determined in mitochondria isolated from the NPC1-/-brains was markedly reduced compared with that in the mitochondria from the NPC1+/-and NPC1-/-brains (Fig. 3e) . As an internal control, immunoblot analysis was performed to determine the amount of VDAC.
These results suggest that the enhanced uncoupling respiratory chain function from ATP synthesis by UCP-2 is not involved in the decreased ATP synthesis in NPC1-/-tissues, and that the expression of UCP-2 is down-regulated possibly due to a negative feedback regulation.
Since there may be a possibility that the decreased levels of ATP and ATP synthase activity are due to indirect consequences caused by neuronal death occurring at 9 weeks of age, we analyzed those parameters in younger mice at 10 days of age. Similar to the results shown in Figs. 2 and 3 , the levels of ATP and ATP synthase activity in NPC1-/-brains were significantly decreased compared to those in NPC1+/+ brains, and cholesterol level was increased in the mitochondria that were isolated from brains of NPC1-/-mice (see Supplemental data; Fig.  S1 ).
The level of cholesterol and phospholipids in cellular fractions and purified mitochondria-Since the most prominent feature of NPC1-/-cells is altered cholesterol metabolism, the concentration of cholesterol and phospholipids in cellular fractions and purified mitochondria fraction (P3) was determined in NPC1+/+, NPC1+/-, and NPC1-/-mouse brains. The results indicated that the concentration of cholesterol was significantly increased in fractions S3 (enriched with plasma membrane, lysosome and endoplasmic reticulum), and P3 (mitochondria), while the concentration of phospholipids was increased only in fraction S3 (Fig. 4a) . This result would therefore exclude the possibility that contamination of lipid between fractions S3 and P3 had occurred. In addition, the concentration of cholesterol was determined for specific membranes purified from mitochondria, specifically the outer membrane (OM), contact sites (CS), and inner membrane (IM). The results indicated that the concentration of cholesterol was significantly increased in both the OM and IM of mitochondria isolated from NPC1-/-mouse brains, compared to the same membranes of mitochondria isolated from NPC1+/+ and NPC1+/-mouse brains (Fig. 4b, upper  panel) . The purity of specific membranes purified from mitochondria was examined and confirmed using immunoblot analysis for proteins associated with the OM (VDAC), CS (fumarase, a matrix marker), and IM (cytochrome c oxidase) (Fig. 4b,  lower panel) . (Fig. 5b) . However, there was no significant difference in the transport of exogenously added PC into mitochondria among the three genotypes (Fig. 5b, lower 
An increase in the level of mitochondria membrane cholesterol inhibits ATP synthase-
To determine whether an increase in mitochondrial cholesterol adversely affects mitochondria function, the activity of ATP synthase was determined in relation to the amount of cholesterol associated with mitochondria isolated from NPC1+/+ and NPC1-/-mouse brains. In order to perform this study, the hydrophilic cholesterol-sequestering agent, methyl--cyclodextrin, was used to remove cholesterol from mitochondria membranes. After incubation of mitochondria with 7.5 mM methyl--cyclodextrin, results indicated that the level of cholesterol associated with NPC1-/-mitochondria, which was significantly increased compared to NPC1+/+ mitochondria, was reduced to a level similar to that of NPC1+/+ mitochondria (Fig. 6b) . In accordance with this decrease in the level of cholesterol associated with NPC1-/-mitochondria, the activity of ATP synthase was significantly increased to a level similar to that of NPC1+/+ mitochondria (Fig. 6a) . Importantly, when the decreased cholesterol level in NPC1-/-mitochondria induced by the incubation with methyl--cyclodextrin was recovered by the subsequent incubation with 50 µM cholesterol (Fig.  6b, right panel) , the enhanced ATP synthase activity induced by methyl--cyclodextrin was reduced to a level similar to that of nontreated NPC1-/-mitochondria (Fig. 6a, right panel) . In addition, the results using NPC1+/+ mitochondria indicate that when cholesterol level in the mitochondria was increased or decreased, the activity of ATP synthase was reduced in either case (Figs. 6a, b ; left panels), suggesting that there is an optimal level of cholesterol in mitochondrial membrane for ATP synthase.
Impaired neuronal outgrowth in NPC1-/-neurons is restored by ATP treatment in culture-
Since ATP is required for the development of neurons (32), the effect of NPC1 deficiency on neurite outgrowth was investigated using neurons prepared from cerebral cortices derived from NPC1+/+, NPC1+/-, and NPC1-/-mouse brains. Using immunocytochemistry, the staining neurons for -tubulin indicated that while neurite extension was clearly evident at 72 h in NPC1+/+ and NPC1+/-neurons, it was impaired in NPC1-/-neurons (Figs. 7Aa, c, e) . In addition, the time-dependent analysis of neurite outgrowth indicated that neurite extension and sprouting were significantly suppressed in NPC1-/-neurons, compared to NPC1+/+ and NPC1+/-neurons (Figs.  7Ba, c) . Importantly, both the neurite length and number were restored upon addition of 0.5 mM ATP (Figs. 4Af and 7Bb, d) . We have confirmed that ATP added extracellularly remains in the medium and increased cellular ATP levels for at least 24 h (see Supplemental data; Fig. S2) . Next, the effect of nucleotides other than ATP, such as ADP and AMP-PNP, on neurite outgrowth was determined. The results indicated that ADP added extracellularly had no significant effect on neurite outgrowth (number and length) in both NPC1+/+ and NPC1-/-neurons (Figs. 7Cc, d ). In contrast, as has been reported previously (33) , the nonhydrolyzable analogue, AMP-PNP, inhibited neurite outgrowth in NPC1+/+ neurons (Figs. 7Cc, d) . The levels of ATP in cultured neurons in the absence or presence of ATP, ADP, or AMP-PNP, were determined. Only the addition of ATP increased the cellular level of ATP (Fig. 7Ca) . These results indicate that deterioration of neurite outgrowth, which is present in NPC1-/-neurons, results from a decreased level of ATP.
DISCUSSION
The molecular mechanism responsible for neurodegeneration in NPC1 disease remains undetermined. The present study describes severe mitochondrial abnormalities that may be responsible for causing impaired neuronal function and neurodegeneration in NPC1-/-mouse brains. The results from this study strongly suggest that neuronal dysfunctions and degeneration in NPC1-/-mouse brains arise from i) a decrease in mitochondrial membrane potential, ii) a decrease in ATP synthesis, and iii) a decrease in the level of cellular ATP. In addition, NPC1-/-neurons exhibited impaired neurite outgrowth, which was restored by the addition of ATP to the culture media. Each of the abnormalities identified in mitochondria of NPC1-/-neurons was associated with an elevation in the cholesterol concentration of mitochondria membranes, and that by reducing the cholesterol concentration of mitochondria membranes, ATP synthase activity was restored to normal.
The results demonstrated that an increase in the level of mitochondria membrane cholesterol impaired mitochondrial function. Additional support for cholesterol being the offending metabolite was confirmed by incubating the water-soluble cholesterol sequestering agent, methyl--cyclodextrin, in the presence of NPC1-/-mitochondria membranes to reduce membrane cholesterol. This reduced NPC1-/-mitochondria membrane cholesterol to a level that was similar to NPC1+/+ mitochondria membranes, and enhanced ATP synthase activity. In addition, recovering cholesterol level in the methyl--cyclodextrin-treated mitochondria by subsequent incubation with cholesterol, decreased ATP synthase activity to an initial level. The increased molar ratio of cholesterol to phospholipids measured in NPC1-/-mitochondria membranes suggests that the basic structure and/or physical property of the mitochondria membrane is adversely affected, and that the altered physical properties of these membranes leads to a reduced proton motive force and membrane potential, which in turn decreases ATP synthesis. In support of this result, previous studies have demonstrated that an elevation of cholesterol concentration in the inner mitochondrial membrane reduces mitochondrial membrane potential, induces mitochondria depolarization and uncoupling responsible for oxidative phosphorylation, and henceforth impairing ATP synthesis (34) (35) (36) . Each of these defects was also observed in NPC1-/-brains and neurons. As a result, it is possible that an increased level of cholesterol within mitochondria membranes, known to adversely influence membrane fluidity (36), leads to impaired mitochondria permeability transition, mitochondrial membrane potential, and ATP synthesis in NPC1-/-cells. Interestingly, the fact that methyl--cyclodextrin treatment also reduced ATP synthesis in NPC1+/+ mitochondria membranes suggests that there is an optimal ratio of cholesterol to phospholipids in mitochondria membranes for ATP synthesis.
Although the NPC1 protein has been shown to facilitate the transport of cholesterol from late endosomes/lysosomes to the trans-Golgi network, the plasma membrane, and the endoplasmic reticulum, the results of this study show that exogenously added cholesterol and endogenously synthesized cholesterol are transported into mitochondria in NPC1-deficient astrocytes. These results suggest the existence of a cholesterol transport pathway independent of the NPC1 protein. The results also suggest that while the cholesterol level in mitochondrial membranes is elevated in NPC1-/-neurons, the phospholipid level in these mitochondria membranes is similar to NPC1+/+ neurons. Finally, since the mitochondria were shown not to be contaminated by late endosomes/lysosomes using both immunoblot analysis and electron microscopy, these results suggest that cholesterol metabolism with respect to the mitochondria may be independently affected in NPC1-/-cells. It is unclear why the level of cholesterol in mitochondrial membranes increases in NPC1-/-brains, although accumulation of cholesterol in late endosome/ lysosome and the increased level of de novo synthesis of cholesterol in NPC1-/-cells may somehow contribute to increased cholesterol transport to the mitochondrial membranes.
The similar cholesterol removal rate from mitochondria in NPC1+/+, NPC1+/-, and NPC1-/-cells suggested that the elevated cholesterol level in NPC1-/-mitochondria may be due to increased cholesterol transport to mitochondria. Several mechanisms have been proposed for phospholipid transport between the mitochondria and other biological membranes (37, 38) . However, cholesterol transport to and from the mitochondria is largely unknown. The results of this study suggest that NPC1 may also modulate cholesterol transport to mitochondria, in addition to the role of NPC1 in cholesterol transport to the trans-Golgi network, the plasma membrane, and the endoplasmic reticulum (39) . Unlike these cellular compartments that become relatively cholesterol-deficient when NPC1 is defective (positive regulation), mitochondria become relatively cholesterol-enriched (negative regulation). Such a mechanism proposed for the function of NPC1 would be consistent with cholesterol serving as the offending metabolite, as it adversely affects critical functions required for mitochondria.
Importantly, it is well established that mitochondria contribute to steroidogenesis. The late-limiting step in steroidogenesis involves the conversion of cholesterol into pregnenolone by cytochrome P450scc and its associated electrontransport chain, which are known to be associated with the inner membrane of mitochondria (40) . In an elegant study recently performed by Griffin et al., it was determined that decreased levels of neurosteroids may actually be the cause of neurodegeneration in NPC1-/-mice (22) . However, it must be emphasized that the mechanism responsible for the loss in neurosteroids and neurosteroidogenic activity remains undefined. Since mitochondria obviously have a critical role in steroidogenesis, the altered function of mitochondria described in the present study is consistent with this organelle having a key role in promoting neurodegeneration.
Recently, there has been evidence suggesting similarities in tauopathy between NPC disease and Alzheimer's disease (AD). The brains of NPC patients have been shown to have neurofibrillary tangles (NFTs) and neurodegeneration without amyloid -protein (A ) deposits (13) , which is believed to be responsible for promoting pathologies typically associated AD. The presence of NFTs is one of the diagnostic hallmarks of AD, and a major component of NFTs is hyperphosphorylated tau. Interestingly, A adversely affects cellular cholesterol metabolism (23, 41) , which in turn, induces tau phosphorylation in cultured neurons (42) . The altered cholesterol metabolism in NPC1-/-brains and cells has also been shown to induce tau phosphorylation in NPC1-/-brains and cells (5, 19) . Moreover, it has now been established that altered cholesterol metabolism is associated with the development of AD (43, 44) , and that mitochondrial dysfunction is involved in the development of AD (45,46). Therefore, it may be possible that AD and NPC share a common pathway involving cholesterol metabolism leading to neurodegeneration via mitochondrial dysfunction (44) .
In conclusion, the present study has demonstrated that an elevation in the level of mitochondria membrane cholesterol, due to deficient NPC1 protein function, decreases cellular ATP levels causing impaired neurite outgrowth and enhanced susceptibility to oxygen radicals, which in turn is supposed to promote neurodegeneration in NPC1-/-mice. Since the addition of ATP can restore impaired neurite outgrowth and high susceptibility to neurotoxicity, supports this notion. This information, suggesting that severe mitochondrial dysfunctions and subsequent decrease in cellular ATP levels may be the cause of neurodegeneration in NPC1 disease, provides a novel insight and direction for pursuing viable treatment options for NPC1 disease. The level of cholesterol, ATP, and ATP synthase activity in brains of 10-dayold mice. The level of cholesterol, ATP, and ATP synthase activity in brains of NPC1+/+ and NPC1-/-mice were determined. The level of cholesterol was not significantly different in homogenates prepared from NPC1+/+ and NPC1-/-mouse brains. However, the level of cholesterol associated with the isolated mitochondria from NPC1-/-mouse brains was increased compared to isolated mitochondria from NPC1+/+ mouse brains (a). In addition, the levels of ATP and ATP synthase activity in the isolated mitochondria from NPC1-/-mouse brains was significantly decreased compared to the isolated mitochondria from NPC1+/+ mouse brains (b and c, respectively). The level of ATP in the media and cultured neurons. The neurons were prepared and cultured in serum-free media. After a period of six hours, the media was removed and replaced with media supplemented with ATP (0.5 mM). The media and cells were then harvested at time points indicated and the level of ATP from each sample was determined. The level of cellular ATP incubated in the presence of exogenous ATP was increased compared to nontreated cells for entire time period that was examined (24 h) (a). In addition, the level of ATP in the media incubated in the presence of exogenous ATP was increased compared to nontreated cells for the entire time period that was examined (24 h) (b). Figure S2 .
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